Impact of electronegative low-density lipoprotein on angiographic coronary atherosclerotic burden

Atherosclerosis

Volumn 223, Issue 1, 2012, Pages 166-170

  Niccoli, Giampaolo ^a   Bacà, Marco ^a   De Spirito, Marco ^a   Parasassi, Tiziana ^b   Cosentino, Nicola ^a   Greco, Giulia ^b   Conte, Micaela ^a   Montone, Rocco Antonio ^a   Arcovito, Giuseppe ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CNR   (Italy)

Author keywords

Coronary atherosclerosis; Electronegative LDL; Ischemic heart disease

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGINA, STABLE; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROME; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84863109855     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.04.005     Document Type: Article

References (26)

1. Ross R. Atherosclerosis: an inflammatory disease. New Engl J Med 1999, 340:115-126.
2. Navab M., Berliner J.A., Watson A.D., Hama S.Y., Territo M.C., Lusis A.J., et al. The Yin and Yang of oxidation in the development of the fatty streak. Arterioscler Thromb Vasc Biol 1996, 16:831-842.
3. Berneis K.K., Krauss R.M. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002, 43:1363-1379.
4. Blake G.J., Otvos J.D., Rifai N., Ridker P.M. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopyas predictors of cardiovascular disease in women. Circulation 2002, 106:1930-1937.
5. Rosenson R.S., Otvos J.D., Freedman D.S. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol 2002, 90:89-94.
6. St-Pierre A.C., Bergeron J., Pirro M., Cantin B., Dagenais G.R., Després J.P., et al. Quebec Cardiovascular Study. Effect of plasma C-reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low-density lipoproteins in men (the Quebec cardiovascular Study). Am J Cardiol 2003, 91:555-558.
7. Itabe H., Obama T., Kato R. The dynamics of oxidized LDL during atherogenesis. J Lipids 2011, 2011:418313. Epub 2011 May 11.
8. Ehara S., Ueda M., Naruko T., Haze K., Matsuo T., Ogami M., et al. Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases. J Diabetes Complications 2002, 16:60-64.
9. Avogaro P., Bittolo-Bon G., Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988, 8:79-87.
10. Mello A.P., da Silva I.T., Abdalla D.S., Damasceno N.R. Electronegative low-density lipoprotein: origin and impact on health and disease. Atherosclerosis 2011, 215:257-265.
11. Védie B., Jeunemaitre X., Mégnien J.L., Myara I., Trébeden H., Simon A., et al. Charge heterogeneity of LDL in asymptomatic hypercholesterolemic men is related to lipid parameters and variations in the apoB and CIII genes. Arterioscler Thromb Vasc Biol 1998, 18:1780-1789.
12. Sánchez-Quesada J.L., Otal-Entraigas C., Franco M., Jorba O., González-Sastre F., Blanco-Vaca F., et al. Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with familial hypercholesterolemia. Am J Cardiol 1999, 84:655-659.
13. Sànchez-Quesada J.L., Benìtez S., Franco M., Franco M., Blanco-Vaca F., Ordóñez-Llanos J. Density distribution of electronegative LDL (LDL(-)) in normolipemic and hyperlipemic subjects. J Lipid Res 2002, 43:699-705.
14. Sánchez-Quesada J.L., Pérez A., Caixàs A., Ordónmez-Llanos J., Carreras G., Payés A., et al. Electronegative low-density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control. Diabetologia 1996, 39:1469-1476.
15. Sánchez-Quesada J.L., Pérez A., Caixàs A., Rigla M., Payés A., Benítez S., et al. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification. J Clin Endocrinol Metab 2001, 86:3243-3249.
16. Moro E., Alessandrini P., Zambon C., Pianetti S., Pais M., Cazzolato G., et al. Is glycation of low density lipoproteins in patients with type 2 diabetes mellitus an LDL pre-oxidative condition?. Diabet Med 1999, 16:663-669.
17. Ziouzenkova O., Asatryan L., Akmal M., Tetta C., Wratten M.L., Loseto-Wich G., et al. Oxidative cross-linking of apoB100 and hemoglobin results in low density lipoprotein modification in blood. J Biol Chem 1999, 27:18916-18924.
18. Tomasik A., Jache W., Skrzep-Poloczek B., Widera-Romuk E., Wodniecki J., Wojciechowska C. Circulating electronegativelycharged low-density lipoprotein in patients with angiographically documented coronary artery disease. Scand J Clin Lab Med 2003, 63:259-266.
19. Oliveira J.A., Sevanian A., Rodrigues R.J., Apolinário E., Abdalla D.S. Minimally modified electronegative LDL and its antibodies in acute and chronic coronary syndromes. Clin Biochem 2006, 39:708-714.
20. Parasassi T., De Spirito M., Mei G., Brunelli R., Greco G., Lenzi L., et al. Low density lipoprotein misfolding and amyloidogenesis. FASEB J 2008, 22:2350-2356.
21. Bogaty P., Brecker S.J., White S.E., Stevenson R.N., el-Tamimi H., Balcon R., et al. Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease. Circulation 1993, 87:1938-1946.
22. Tsimikas S., Bergmark C., Beyer R.W., Patel R., Pattison J., Miller E., et al. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 2003, 41:360-370.
23. Anselmi M., Garbin U., Agostoni P., Fusaro M., Pasini A.F., Nava C., et al. Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques. Atherosclerosis 2006, 85:114-120.
24. Patel J.V., Abraheem A., Creamer J., Gunning M., Hughes E.A., Lip G.Y. Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease. Eur J Heart Fail 2010, 12:254-259.
25. Abela G.S., Aziz K. Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events-a novel insight into plaque rupture by scanning electron microscopy. Scanning 2006, 28:1-10.
26. Berry C., L'Allier P.L., Grégoire J., Lespérance J., Levesque S., Ibrahim R., et al. Comparison of intravascular ultrasoundand quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation 2007, 115:1851-1857.